மரம் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மரம் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மரம் மருந்துகள் Today - Breaking & Trending Today

Timber Pharmaceuticals Receives Decision to Grant Japanese Patent for Lead Asset TMB-001


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Timber Pharmaceuticals Receives Decision to Grant Japanese Patent for Lead Asset TMB-001
Timber PharmaceuticalsApril 28, 2021 GMT
- Company is evaluating a topical pharmaceutical composition of isotretinoin for the treatment of moderate to severe subtypes of congenital ichthyosis -
Basking Ridge, NJ, April 28, 2021 (GLOBE NEWSWIRE) via NewMediaWire   Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that the Japanese Patent Office has decided to grant a patent (No. 2018-542677) for its lead asset, TMB-001, the Company’s topical pharmaceutical composition of isotretinoin that is currently being evaluated for the treatment of moderate to severe subtypes of congenital ichthyosis (CI). ....

United States , Adam Daley , John Koconis , Exchange Commission , Newmediawire Timber Pharmaceuticals Inc , Company Annual Report On Form , Berry Company Public Relations , Securities Exchange , Timber Pharmaceuticals Inc , Japanese Patent Office , Chief Executive Officer , Orphan Products Clinical Trials Grant , Timber Pharmaceuticals , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Company Public Relations , Globe Newswire , ஒன்றுபட்டது மாநிலங்களில் , ஆடம் டேலி , பரிமாற்றம் தரகு , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , பெர்ரி நிறுவனம் பொது உறவுகள் , பத்திரங்கள் பரிமாற்றம் , மரம் மருந்துகள் இன்க் ,